マーケットレポート詳細
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
微生物発酵技術の世界市場規模は2022年で309億ドル、2031年に496億ドル、市場の平均年成長率は5.5%になると予想されています。
当レポートでは、微生物発酵技術の市場予測-2031年、各種セグメント別市場分析(製品別、エンドユーザー産業別、国地域別)、COVID-19の影響分析、競合状況、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
・市場規模(US$)
メディカル
・抗生物質
・プロバイオティクス
・モノクローナル抗体
・組み換えタンパク質
・その他バイオシミラー
インダストリアル
・アセトン/エタノール/ブタノール
・酵素/アミノ酸
アルコール飲料
・ビール
・スピリッツ
・ワイン
・その他
食品/飼料
※(市場規模US$)
バイオ医薬品
食品/飼料
医薬品開発業務受託機関(CRO)/医薬品製造業務受託機関(CMO)
学術研究機関
その他
※(市場規模US$)
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
市場ダイナミクス(促進要因、障壁、機会)
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析
Biocon
Danone Ltd.
Lonza
United Breweries Ltd.
Amyris
Novozymes
TerraVia Holdings, Inc.
BioVectra
DSM
F. Hoffmann La-Roche Ltd.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Microbial Fermentation Technology Market Analysis and Forecast, 2022-2031
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Medical
6.3.1.1. Antibiotics
6.3.1.2. Probiotics
6.3.1.3. Monoclonal Antibodies
6.3.1.4. Recombinant Proteins
6.3.1.5. Other Biosimilars
6.3.2. Industrial
6.3.2.1. Acetone, Ethanol & Butanol
6.3.2.2. Enzymes & Amino Acids
6.3.3. Alcoholic Beverages
6.3.3.1. Beer
6.3.3.2. Spirits
6.3.3.3. Wine
6.3.3.4. Others
6.3.4. Food & Feed Products
6.4. Market Attractiveness, by Product
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user Industry, 2017–2031
7.3.1. Biopharmaceutical
7.3.2. Food & Feed
7.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
7.3.4. Academic Research Institutes
7.3.5. Others
7.4. Market Attractiveness, by End-user Industry
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2022–2031
9.2.1. Medical
9.2.1.1. Antibiotics
9.2.1.2. Probiotics
9.2.1.3. Monoclonal Antibodies
9.2.1.4. Recombinant Proteins
9.2.1.5. Other Biosimilars
9.2.2. Industrial
9.2.2.1. Acetone, Ethanol & Butanol
9.2.2.2. Enzymes & Amino Acids
9.2.3. Alcoholic Beverages
9.2.3.1. Beer
9.2.3.2. Spirits
9.2.3.3. Wine
9.2.3.4. Others
9.2.4. Food & Feed Products
9.3. Market Value Forecast, by End-user Industry, 2022–2031
9.3.1. Biopharmaceutical
9.3.2. Food & Feed
9.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
9.3.4. Academic Research Institutes
9.3.5. Others
9.4. Market Value Forecast, by Country, 2022–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user Industry
9.5.3. By Country
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2022–2031
10.2.1. Medical
10.2.1.1. Antibiotics
10.2.1.2. Probiotics
10.2.1.3. Monoclonal Antibodies
10.2.1.4. Recombinant Proteins
10.2.1.5. Other Biosimilars
10.2.2. Industrial
10.2.2.1. Acetone, Ethanol & Butanol
10.2.2.2. Enzymes & Amino Acids
10.2.3. Alcoholic Beverages
10.2.3.1. Beer
10.2.3.2. Spirits
10.2.3.3. Wine
10.2.3.4. Others
10.2.4. Food & Feed Products
10.3. Market Value Forecast, by End-user Industry, 2022–2031
10.3.1. Biopharmaceutical
10.3.2. Food & Feed
10.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
10.3.4. Academic Research Institutes
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2022–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user Industry
10.5.3. By Country/Sub-region
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2022–2031
11.2.1. Medical
11.2.1.1. Antibiotics
11.2.1.2. Probiotics
11.2.1.3. Monoclonal Antibodies
11.2.1.4. Recombinant Proteins
11.2.1.5. Other Biosimilars
11.2.2. Industrial
11.2.2.1. Acetone, Ethanol & Butanol
11.2.2.2. Enzymes & Amino Acids
11.2.3. Alcoholic Beverages
11.2.3.1. Beer
11.2.3.2. Spirits
11.2.3.3. Wine
11.2.3.4. Others
11.2.4. Food & Feed Products
11.3. Market Value Forecast, by End-user Industry, 2022–2031
11.3.1. Biopharmaceutical
11.3.2. Food & Feed
11.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
11.3.4. Academic Research Institutes
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2022–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user Industry
11.5.3. By Country/Sub-region
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2022–2031
12.2.1. Medical
12.2.1.1. Antibiotics
12.2.1.2. Probiotics
12.2.1.3. Monoclonal Antibodies
12.2.1.4. Recombinant Proteins
12.2.1.5. Other Biosimilars
12.2.2. Industrial
12.2.2.1. Acetone, Ethanol & Butanol
12.2.2.2. Enzymes & Amino Acids
12.2.3. Alcoholic Beverages
12.2.3.1. Beer
12.2.3.2. Spirits
12.2.3.3. Wine
12.2.3.4. Others
12.2.4. Food & Feed Products
12.3. Market Value Forecast, by End-user Industry, 2022–2031
12.3.1. Biopharmaceutical
12.3.2. Food & Feed
12.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
12.3.4. Academic Research Institutes
12.3.5. Others
12.4. Market Value Forecast, by Country/Sub-region, 2022–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user Industry
12.5.3. By Country/Sub-region
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2022–2031
13.2.1. Medical
13.2.1.1. Antibiotics
13.2.1.2. Probiotics
13.2.1.3. Monoclonal Antibodies
13.2.1.4. Recombinant Proteins
13.2.1.5. Other Biosimilars
13.2.2. Industrial
13.2.2.1. Acetone, Ethanol & Butanol
13.2.2.2. Enzymes & Amino Acids
13.2.3. Alcoholic Beverages
13.2.3.1. Beer
13.2.3.2. Spirits
13.2.3.3. Wine
13.2.3.4. Others
13.2.4. Food & Feed Products
13.3. Market Value Forecast, by End-user Industry, 2022–2031
13.3.1. Biopharmaceutical
13.3.2. Food & Feed
13.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
13.3.4. Academic Research Institutes
13.3.5. Others
13.4. Market Value Forecast, by Country/Sub-region, 2022–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user Industry
13.5.3. By Country/Sub-region
14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Biocon
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Danone Limited
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Lonza
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. United Breweries Ltd.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Amyris
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Novozymes
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. TerraVia Holdings, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. BioVectra
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. DSM
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. F. Hoffmann La-Roche Ltd.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
Table 1: Global Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Product, 2017–2031:
Table 2: Global Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by End-user Industry, 2017–2031:
Table 3: Global Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Region, 2017–2031:
Table 4: North America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Country, 2017–2031
Table 5: North America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 6: North America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by End-user Industry, 2017–2031
Table 7: Europe Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 8: Europe Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Product, 2017–2031:
Table 9: Europe Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by End-user Industry 2017–2031:
Table 10: Asia Pacific Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by End-user Industry, 2017–2031:
Table 13: Latin America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 15: Latin America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by End-user Industry 2017–2031
Table 16: Middle East & Africa Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 18: Middle East & Africa Microbial Fermentation Technology Market Value (US$ Bn) Forecast, by End-user Industry 2017–2031
Figure 1: Global Microbial Fermentation Technology Market Value (US$ Bn) Forecast, 2017–2031
Figure 2: Global Microbial Fermentation Technology Market Value Share, by Product, 2022
Figure 3: Global Microbial Fermentation Technology Market Value Share, by End-user Industry, 2022
Figure 4: Global Microbial Fermentation Technology Market Value Share Analysis, by Product, 2022 and 2031
Figure 5: Global Microbial Fermentation Technology Market Attractiveness Analysis, by Product, 2023–2031
Figure 6: Global Microbial Fermentation Technology Market Value Share Analysis, by End-user Industry, 2022 and 2031
Figure 7: Global Microbial Fermentation Technology Market Attractiveness Analysis, by End-user Industry 2023–2031
Figure 8: Global Microbial Fermentation Technology Market Value Share Analysis, by Region, 2022 and 2031
Figure 9: Global Microbial Fermentation Technology Market Attractiveness Analysis, by Region, 2023–2031
Figure 10: North America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, 2017–2031
Figure 11: North America Microbial Fermentation Technology Market Value Share Analysis, by Country, 2022 and 2031
Figure 12: North America Microbial Fermentation Technology Market Attractiveness Analysis, by Country, 2023–2031
Figure 13: North America Microbial Fermentation Technology Market Value Share Analysis, by Product, 2022 and 2031
Figure 14: North America Microbial Fermentation Technology Market Attractiveness Analysis, by Product, 2023–2031
Figure 15: North America Microbial Fermentation Technology Market Value Share Analysis, by End-user Industry, 2022 and 2031
Figure 16: North America Microbial Fermentation Technology Market Attractiveness Analysis, by End-user Industry 2023–2031
Figure 17: Europe Microbial Fermentation Technology Market Value (US$ Bn) Forecast, 2017–2031
Figure 18: Europe Microbial Fermentation Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 19: Europe Microbial Fermentation Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 20: Europe Microbial Fermentation Technology Market Value Share Analysis, by Product, 2022 and 2031
Figure 21: Europe America Microbial Fermentation Technology Market Attractiveness Analysis, by Product, 2023–2031
Figure 22: Europe Microbial Fermentation Technology Market Value Share Analysis, by End-user Industry, 2022 and 2031
Figure 23: Europe Microbial Fermentation Technology Market Attractiveness Analysis, by End-user Industry 2023–2031
Figure 24: Asia Pacific Microbial Fermentation Technology Market Value (US$ Bn) Forecast, 2017–2031
Figure 25: Asia Pacific Microbial Fermentation Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 26: Asia Pacific Microbial Fermentation Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 27: Asia Pacific Microbial Fermentation Technology Market Value Share Analysis, by Product, 2022 and 2031
Figure 28: Asia Pacific America Microbial Fermentation Technology Market Attractiveness Analysis, by Product, 2023–2031
Figure 29: Asia Pacific Microbial Fermentation Technology Market Value Share Analysis, by End-user Industry, 2022 and 2031
Figure 30: Asia Pacific Microbial Fermentation Technology Market Attractiveness Analysis, by End-user Industry 2023–2031
Figure 31: Latin America Microbial Fermentation Technology Market Value (US$ Bn) Forecast, 2017–2031
Figure 32: Latin America Microbial Fermentation Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 33: Latin America Microbial Fermentation Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 34: Latin America Microbial Fermentation Technology Market Value Share Analysis, by Product, 2022 and 2031
Figure 35: Latin America Microbial Fermentation Technology Market Attractiveness Analysis, by Product, 2023–2031
Figure 36: Middle East & Africa Microbial Fermentation Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 37: Middle East & Africa Microbial Fermentation Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Middle East & Africa America Microbial Fermentation Technology Market Value Share Analysis, by Product, 2023–2031
Figure 39: Middle East & Africa America Microbial Fermentation Technology Market Attractiveness Analysis, by Product, 2023–2031
Figure 40: Middle East & Africa Microbial Fermentation Technology Market Value Share Analysis, by End-user Industry, 2022 and 2031
Figure 41: Middle East & Africa Microbial Fermentation Technology Market Attractiveness Analysis, by End-user Industry 2023–2031
Figure 42: Global Microbial Fermentation Technology Market Share Analysis, by Company (2022)